≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other specified congenital malformation syndromes affecting multiple systems

EFO MESH Endpoint Browser PheWeb

Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — Q87
  • Cause of death: ICD-10 — Q87

2 out of 7 registries used, show all original rules.

619

4. Check minimum number of events

None

619

5. Include endpoints

None

619

6. Filter based on genotype QC (FinnGen only)

619

Control definitions (FinnGen only)

Control exclude
Q17_OTHER_CONGEN_MALFO

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
Q8
Name in latin
Alia syndromata malformationum congenitarum specificata, systemata multa afficientia

Similar endpoints

↥

List of similar endpoints to Other specified congenital malformation syndromes affecting multiple systems based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Similar with more cases:

Venn diagram with a set fully inside an highlighted set Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 5896 2910 2971
Only index persons 4570 2275 2295
Unadjusted period prevalence (%)
Whole population 0.08 0.08 0.08
Only index persons 0.09 0.08 0.09
Median age at first event (years)
Whole population 7.85 8.55 7.03
Only index persons 11.81 12.91 10.72

-FinnGen-

Key figures

All Female Male
Number of individuals 619 332 287
Unadjusted period prevalence (%) 0.12 0.11 0.13
Median age at first event (years) 22.25 23.53 20.76

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
563
Matched controls
5630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q87.4
ICD-10 Finland
Marfan syndrome
+∞
200.2
180
*
Z31.5
ICD-10 Finland
Genetic counselling
23.5
162.5
248
182
Q87.88
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
121.3
112
*
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
8.5
73.5
181
298
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
46.9
66.6
81
20
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
5.9
59.8
198
474
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
52.8
269
991
ZXD10
NOMESCO Finland
Scheduled procedure
3.8
47.7
312
1392
ZXE10
NOMESCO Finland
More than one and less than three hours
3.8
46.9
287
1208
ZXE20
NOMESCO Finland
More than three and less than five hours
5.4
46.4
158
376
Q87.09
ICD-10 Finland
Other congenital malformations that mainly affect the appearance of the face
484.3
45.9
45
*
Q87.80
ICD-10 Finland
Alport syndrome
+∞
45.4
43
*
XF400
NOMESCO Finland
ECG with 12 standard connections
4.7
44.3
179
509
Z2221
NOMESCO Finland
Medical doctor
3.7
43.0
261
1068
I71.9
ICD-10 Finland
Aortic aneurysm of unspecified site, without mention of rupture
97.5
41.4
45
5
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
14.6
40.8
70
54
Z01.0
ICD-10 Finland
Examination of eyes and vision
4.1
39.0
180
572
Q87.14
ICD-10 Finland
Noonan's syndrome
+∞
37.9
36
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.3
37.8
266
1186
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
5.9
36.4
111
226
R4110
NOMESCO Finland
Physiotherapy
3.4
35.6
224
907
Z01.1
ICD-10 Finland
Examination of ears and hearing
4.2
35.6
159
485
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
10.3
35.5
72
79
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.7
35.4
136
358
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
7.7
35.2
86
129
PD5CG
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
101.5
35.2
38
*
F83
ICD-10 Finland
Mixed specific developmental disorders
10.2
32.6
66
72
Q87.21
ICD-10 Finland
Klippel-Trénaunay-Weber syndrome
+∞
31.5
30
*
ZXE00
NOMESCO Finland
One hour or less
2.9
31.4
298
1568
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
30.3
203
841
PD5BD
NOMESCO Finland
Extensive CT of aorta
28.5
29.7
40
15
B01AA03
ATC
warfarin; systemic
5.4
29.7
96
207
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
5.2
29.3
98
219
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.9
29.0
103
246
F70.0
ICD-10 Finland
Mild mental retardation, With the statement of no, or minimal, impairment of behaviour
23.8
28.2
40
18
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.5
27.9
88
184
R62.0
ICD-10 Finland
Delayed milestone
8.4
27.0
61
80
Z3229
NOMESCO Finland
Other healthcare associate professional
4.5
27.0
104
269
Z3226
NOMESCO Finland
Physiotherapist
3.1
27.0
179
727
ZXA10
NOMESCO Finland
Bilateral
3.4
26.9
150
536
H01AC01
ATC
somatropin; parenteral
9.4
26.1
55
64
FCA60
NOMESCO Finland
Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis
272.0
25.9
26
*
Q87.19
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
+∞
25.2
24
*
Q87.06
ICD-10 Finland
Velocardiofacial syndrome
+∞
25.2
24
*
I71.00
ICD-10 Finland
Dissecting aneurysm of aorta (ruptured) [any part]
+∞
24.1
23
*
Z3231
NOMESCO Finland
Registered nurse
2.6
24.1
233
1184
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
24.0
136
488
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
16.9
24.0
38
24
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
5.1
23.8
79
174
H27.1
ICD-10 Finland
Dislocation of lens
130.3
23.8
25
*
H52.1
ICD-10 Finland
Myopia
6.2
23.6
66
118
I34.1
ICD-10 Finland
Mitral (valve) prolapse
14.8
23.4
39
28
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
21.2
23.3
34
17
I71.09
ICD-10 Finland
Aortic dissection [regardless of location]
67.8
23.0
26
*
WX872
NOMESCO Finland
Intensive care
9.6
22.8
47
53
WX002
NOMESCO Finland
Sedation and analgesia
3.4
22.7
122
418
XF404
NOMESCO Finland
Ambulatory ECG
4.6
22.5
82
199
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
22.3
149
596
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
10.3
22.2
44
46
H52.2
ICD-10 Finland
Astigmatism
7.8
21.8
51
71
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.2
21.5
69
146
ZXA00
NOMESCO Finland
Right side
2.9
21.2
148
606
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
5.4
20.6
64
130
Z2446
NOMESCO Finland
Social worker
3.3
20.4
116
411
C03CA01
ATC
furosemide; systemic
3.7
20.4
96
295
Q89.7
ICD-10 Finland
Multiple congenital malformations, not elsewhere classified
+∞
19.9
19
*
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.4
19.9
44
56
I71.01
ICD-10 Finland
Aneurysm of the descending aorta
206.6
19.7
20
*
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
4.4
19.5
73
182
101
Kela drug reimbursment
Anterior pituitary hypofunction
9.9
19.4
39
42
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
20.9
19.2
28
14
Q87.8
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
18.8
18
*
Q87.16
ICD-10 Finland
Mulibrey nanism
+∞
18.8
18
*
C07AB07
ATC
bisoprolol; oral
2.5
18.7
180
884
201
Kela drug reimbursment
Chronic cardiac insufficiency
8.4
18.6
41
52
UDC00
NOMESCO Finland
Ear microscopy
4.1
18.4
75
202
TPH07
NOMESCO Finland
Cathetrisation of artery
3.7
18.4
87
267
ZXD05
NOMESCO Finland
Urgent procedure
2.4
18.3
204
1080
C01AA05
ATC
digoxin; systemic
10.6
18.1
35
35
Q22.1
ICD-10 Finland
Congenital pulmonary valve stenosis
34.1
18.1
23
7
Z01.8
ICD-10 Finland
Other specified special examinations
2.7
18.1
146
649
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
12.5
18.0
32
27
NK6MA
NOMESCO Finland
Measurement of bone age from hand and elbow using X-ray
4.6
18.0
65
156
DFF00
NOMESCO Finland
Pure tone audiometry
4.5
18.0
66
161
ZXA05
NOMESCO Finland
Left side
2.8
17.8
129
536
7598B
ICD-9 Finland
Other and unspecified congenital anomalies, Other specified anomalies[SYNDROMA MARFAN]
+∞
17.8
17
*
Q87.30
ICD-10 Finland
Syndrome Beckwith-Wiedemann
+∞
17.8
17
*
F82
ICD-10 Finland
Specific developmental disorder of motor function
8.4
17.3
38
48
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.3
16.9
94
326
Q82.50
ICD-10 Finland
Naevus flammeus
+∞
16.7
16
*
RL140
NOMESCO Finland
NA
11.2
16.6
31
29
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
3.8
16.5
73
211
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.5
16.1
142
659
P85
ICPC
Mental retardation
12.7
16.0
28
23
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
9.1
15.9
33
38
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.7
15.8
125
544
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
6.4
15.6
41
68
WX402
NOMESCO Finland
General anaesthesia
2.5
15.6
145
688
WX892
NOMESCO Finland
Monitored bed care
3.7
15.5
70
206
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
20.7
15.2
22
11
301
Kela drug reimbursment
Growth hormone
11.2
15.1
28
26
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
9.3
15.1
31
35
UGC02
NOMESCO Finland
Rigid bronchoscopy
17.0
14.9
23
14
SAA04
NOMESCO Finland
Special inverstigation of mouth
3.2
14.8
83
289
75988
ICD-8 Finland
Congenital syndromes affecting multiple systems, Aliae definitae
+∞
14.6
14
*
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.1
14.6
84
298
XFE00
NOMESCO Finland
Epicardial ultrasonography
10.4
14.6
28
28
B01AB05
ATC
enoxaparin; parenteral
2.5
14.6
129
596
ZXD20
NOMESCO Finland
Day surgery
3.0
14.4
89
330
FM2CE
NOMESCO Finland
NA
4.3
14.4
54
135
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
3.1
14.3
82
290
R4130
NOMESCO Finland
Speech therapy
5.5
14.2
42
81
Q35.1
ICD-10 Finland
Cleft hard palate
43.6
14.2
17
*
C09CA01
ATC
losartan; oral
2.9
14.0
91
350
C07AB03
ATC
atenolol; systemic
8.3
13.7
30
38
Q21.08
ICD-10 Finland
Other specifed ventricular septal defect
8.3
13.7
30
38
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
8.7
13.7
29
35
Q87.26
ICD-10 Finland
VATER association
+∞
13.6
13
*
Q87.0
ICD-10 Finland
Congenital malformation syndromes predominantly affecting facial appearance
+∞
13.6
13
*
Q21.10
ICD-10 Finland
Persistent ostium secundum
6.7
13.6
34
53
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.5
13.5
66
207
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
16.7
13.5
21
13
Q53.2
ICD-10 Finland
Undescended testicle, bilateral
26.4
13.4
18
7
SPAT1229
SPAT
Assessment of need for aid
5.4
13.1
39
76
A12AA04
ATC
calcium carbonate; oral
9.1
13.1
27
31
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
9.7
13.1
26
28
TJD20
NOMESCO Finland
Change of gastrostomy tube
10.4
13.1
25
25
R4120
NOMESCO Finland
Occupational therapy
3.8
13.1
56
158
Z96.1
ICD-10 Finland
Presence of intraocular lens
5.0
13.0
42
90
EBA15
NOMESCO Finland
Extraction of large number of teeth
5.4
13.0
39
77
KA1AE
NOMESCO Finland
Kidney ultrasound examination
8.3
12.9
28
35
L28
ICPC
Limited function/disability (L)
3.3
12.9
67
221
R1260
NOMESCO Finland
Evaluation of communicative skills
9.3
12.8
26
29
TFP20
NOMESCO Finland
Cardiodefibrillation
5.1
12.8
40
83
XX9AW
NOMESCO Finland
Production of copy from X-ray picture
6.2
12.7
34
58
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.1
12.7
50
131
Q35.71
ICD-10 Finland
Submucous cleft palate
71.4
12.6
14
*
Q25.0
ICD-10 Finland
Patent ductus arteriosus
9.0
12.6
26
30
PD5CM
NOMESCO Finland
Extensive MRI examination of thoracal and abdominal aorta with 3 Tesla magnet
+∞
12.5
12
*
H50.0
ICD-10 Finland
Convergent concomitant strabismus
8.7
12.4
26
31
Q21.00
ICD-10 Finland
Multiple ventricular septal defect
10.8
12.3
23
22
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
14.7
12.3
20
14
XA800
NOMESCO Finland
Neuropsychological investigation
3.3
12.3
63
205
H65.3
ICD-10 Finland
Chronic mucoid otitis media
3.2
12.3
68
233
XF640
NOMESCO Finland
NA
10.4
12.1
23
23
JDB10
NOMESCO Finland
Percutaneous gastrostomy
10.4
12.1
23
23
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
7.0
12.0
29
43
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.0
12.0
29
43
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.4
12.0
43
103
RS222
NOMESCO Finland
NA
8.2
11.9
26
33
GD1AD
NOMESCO Finland
Thorax CT examination
5.8
11.8
33
60
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
16.8
11.7
18
11
Z95.8
ICD-10 Finland
Presence of other cardiac and vascular implants and grafts
30.7
11.7
15
5
I50.9
ICD-10 Finland
Heart failure, unspecified
4.7
11.7
39
87
AJ1
HP
Reconstruction of the aortic base, eg composite graft, incl. valve saving operation
66.2
11.6
13
*
C03DA01
ATC
spironolactone; oral
3.8
11.6
49
137
XF402
NOMESCO Finland
ECG with work load test
3.6
11.5
53
159
Q87.28
ICD-10 Finland
Congenital malformation syndromes predominantly involving limbs
+∞
11.5
11
*
Q87.04
ICD-10 Finland
Syndrome Robin
+∞
11.5
11
*
Q87.1
ICD-10 Finland
Congenital malformation syndromes predominantly associated with short stature
+∞
11.5
11
*
Q87.15
ICD-10 Finland
Prader-Willi syndrome
+∞
11.5
11
*
Q87.5
ICD-10 Finland
Other congenital malformation syndromes with other skeletal changes
+∞
11.5
11
*
7597A
ICD-9 Finland
Other and unspecified congenital anomalies, Multiple congenital anomalies, so described
+∞
11.5
11
*
D82.1
ICD-10 Finland
Di George syndrome
+∞
11.5
11
*
Q87.03
ICD-10 Finland
Syndrome Goldenhar
+∞
11.5
11
*
I71.1
ICD-10 Finland
Thoracic aortic aneurysm, ruptured
122.2
11.5
12
*
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
122.2
11.5
12
*
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.3
11.3
119
591
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.5
11.3
53
162
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.3
11.0
109
525
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
5.1
11.0
34
70
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
10.8
260
1786
PD5BG
NOMESCO Finland
MRI examination of thoracal and abdominal aortta with high intensity magnet
61.1
10.7
12
*
XF600
NOMESCO Finland
Bloodpressure measurement
2.8
10.6
69
264
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
5.2
10.6
32
64
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
6.7
10.6
26
40
RS220
NOMESCO Finland
NA
6.1
10.5
28
48
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
3.8
10.5
44
122
FCA75
NOMESCO Finland
Valve-sparing repair of aortic root (David, Yacoub)
111.8
10.4
11
*
FCD60
NOMESCO Finland
Resection of thoracoabdominal aorta and reimplantation of branches
+∞
10.4
10
*
Q87.31
ICD-10 Finland
Syndrome Sotos
+∞
10.4
10
*
Q87.38
ICD-10 Finland
Syndrome Weaver
+∞
10.4
10
*
R5120
NOMESCO Finland
Preparation of an aid
9.0
10.3
21
24
Q21.09
ICD-10 Finland
Ventricular septal defect NOS
9.8
10.3
20
21
F71.0
ICD-10 Finland
Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour
19.2
10.3
15
8
DFF20
NOMESCO Finland
Audiometry for children
6.8
10.3
25
38
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
13.4
10.2
17
13
RT160
NOMESCO Finland
NA
11.6
10.1
18
16
H52.0
ICD-10 Finland
Hypermetropia
4.3
10.0
36
87
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
7.2
9.9
23
33
AA5HE
NOMESCO Finland
Brain ultrasound examination in a child
5.1
9.9
30
61
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
9.0
9.8
20
23
EB1WA
NOMESCO Finland
NA
10.9
9.8
18
17
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
3.9
9.8
40
109
F80.1
ICD-10 Finland
Expressive language disorder
5.7
9.8
27
49
CG2T4
NOMESCO Finland
Topography assessment of cornea
13.7
9.7
16
12
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.0
9.7
135
757
A11CC03
ATC
alfacalcidol; systemic
5.4
9.6
28
54
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
5.4
9.6
28
54
H53.0
ICD-10 Finland
Amblyopia ex anopsia
5.4
9.6
28
54
KFH00
NOMESCO Finland
Operation for undescended or ectopic testis
8.6
9.6
20
24
TK800
NOMESCO Finland
Hemodialysis
7.3
9.6
22
31
ZX120
NOMESCO Finland
Intravenous
2.7
9.6
66
261
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.4
9.5
46
144
4122
FHL
Tympanostomy (tympanic tube)
5.1
9.5
29
59
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.2
9.5
49
161
Z97.4
ICD-10 Finland
Presence of external hearing-aid
7.7
9.5
21
28
Q87.84
ICD-10 Finland
Williams syndrome
101.5
9.4
10
*
Q99.8
ICD-10 Finland
Other specified chromosome abnormalities
17.9
9.4
14
8
FCC50
NOMESCO Finland
Resection and reconstruction of descending aorta using tube graft
+∞
9.4
9
*
75980
ICD-8 Finland
Congenital syndromes affecting multiple systems, Syndroma Marfan, arachnodactylia
+∞
9.4
9
*
H27.0
ICD-10 Finland
Aphakia
+∞
9.4
9
*
Q27.4
ICD-10 Finland
Congenital phlebectasia
22.1
9.4
13
6
TLC00
NOMESCO Finland
Insertion of intrauterine device
3.1
9.4
50
169
WX882
NOMESCO Finland
High dependency care
3.0
9.2
54
194
J01MA12
ATC
levofloxacin; systemic
2.5
9.2
73
314
A03FA02
ATC
cisapride; oral, rectal
3.6
9.1
40
117
ZXC12
NOMESCO Finland
Pulse colorlaser
37.3
9.0
11
*
Q53.1
ICD-10 Finland
Undescended testicle, unilateral
7.6
9.0
20
27
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
18.9
9.0
13
7
H81
ICPC
Excessive ear wax
2.6
8.9
64
261
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.9
8.9
55
203
Z50.5
ICD-10 Finland
Speech therapy
3.5
8.9
40
119
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
5.8
8.8
24
43
N02AX02
ATC
tramadol; systemic, rectal
1.9
8.8
162
1002
K83
ICPC
Heart valve disease NOS
14.3
8.7
14
10
Q21.30
ICD-10 Finland
Tetralogy of Fallot
14.3
8.7
14
10
Q76.30
ICD-10 Finland
Hemivertebra fusion or failure of segmentation with scoliosis
50.7
8.7
10
*
PD5DG
NOMESCO Finland
Very extensive MRI examination of thoracal and abdominal aortta with high intensity magnet
50.7
8.7
10
*
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
6.3
8.7
22
36
K03.66
ICD-10 Finland
Tooth plaque
2.4
8.7
76
345
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.0
8.6
49
172
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
8.4
8.6
18
22
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
8.6
145
867
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.8
8.6
35
96
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.6
8.6
64
266
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
16.6
8.6
13
8
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
5.3
8.6
25
49
Q66.0
ICD-10 Finland
Talipes equinovarus
27.9
8.5
11
*
62
HP
Catheterization and pressure measurement of the right side of the heart
27.9
8.5
11
*
Q67.0
ICD-10 Finland
Facial asymmetry
91.2
8.4
9
*
PDG51
NOMESCO Finland
Bypass from aorta to iliac artery for aneurysm
91.2
8.4
9
*
7598X
ICD-9 Finland
Other and unspecified congenital anomalies, Other specified anomalies[ANOMALIAE CONGENITAE ALIAE DEFINITAE]
91.2
8.4
9
*
EHC30
NOMESCO Finland
Reconstruction of palate
+∞
8.3
8
*
Q79.8
ICD-10 Finland
Other congenital malformations of musculoskeletal system
+∞
8.3
8
*
Q87.82
ICD-10 Finland
Zellweger syndrome
+∞
8.3
8
*
Q87.10
ICD-10 Finland
Aarskog syndrome
+∞
8.3
8
*
PD5AD
NOMESCO Finland
CT of aorta
11.0
8.3
15
14
RL130
NOMESCO Finland
NA
6.6
8.2
20
31
EEC05
NOMESCO Finland
Le Fort I osteotomy
14.7
8.2
13
9
WX140
NOMESCO Finland
Parabulbar anesthesy
6.2
8.2
21
35
Z94.0
ICD-10 Finland
Kidney transplant status
6.2
8.2
21
35
RT150
NOMESCO Finland
NA
6.2
8.2
21
35
AA1AD
NOMESCO Finland
CT of head and brain
2.2
8.2
82
397
R50.9
ICD-10 Finland
Fever, unspecified
2.0
8.1
111
611
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
11.9
8.1
14
12
M41.5
ICD-10 Finland
Other secondary scoliosis
33.8
8.1
10
*
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
33.8
8.1
10
*
N18.8
ICD-10 Finland
Other chronic renal failure
6.4
8.1
20
32
R04.0
ICD-10 Finland
Epistaxis
3.5
8.1
36
107
R56.8
ICD-10 Finland
Other and unspecified convulsions
2.7
8.0
54
211
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
3.5
8.0
36
108
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
7.9
7.9
17
22
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
5.5
7.9
22
41
K84
ICPC
Heart disease other
6.2
7.9
20
33
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.1
7.9
42
143
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.2
7.8
39
126
127
Kela drug reimbursment
Transplant complication
5.0
7.8
24
50
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
7.8
94
495
C07AA07
ATC
sotalol; systemic
6.0
7.7
20
34
F70.1
ICD-10 Finland
Mild mental retardation, Significant impairment of behaviour requiring attention or treatment
15.3
7.7
12
8
Q27.88
ICD-10 Finland
Other specified congenital malformation of peripheral vascular system
45.5
7.7
9
*
Q27.3
ICD-10 Finland
Peripheral arteriovenous malformation
45.5
7.7
9
*
H61.2
ICD-10 Finland
Impacted cerumen
3.4
7.7
36
111
FM1DG
NOMESCO Finland
Very extensive MRI examination of heart with high intesity magnet
7.6
7.7
17
23
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
7.6
52
206
Q82.58
ICD-10 Finland
Congenital non-neoplastic naevus
25.3
7.6
10
*
RD210
NOMESCO Finland
NA
3.1
7.6
41
141
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
9.0
7.6
15
17
WZC30
NOMESCO Finland
Teaching
2.3
7.5
68
312
H50.30
ICD-10 Finland
Intermittent esotropy
6.6
7.5
18
28
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
5.4
7.4
21
40
E34.39
ICD-10 Finland
Short stature, not elsewhere classified
5.4
7.4
21
40
QBA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of trunk
81.0
7.4
8
*
A90
ICPC
Congenital anomaly NOS/multiple
81.0
7.4
8
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.9
7.4
44
161
CJB10
NOMESCO Finland
Laser discission of secondary cataract
4.8
7.4
23
49
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.9
7.4
123
730
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.0
7.4
42
148
A06AD11
ATC
lactulose; oral
2.7
7.4
50
196
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.7
7.4
169
1112
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
7.0
7.3
17
25
FM1CG
NOMESCO Finland
Extensive examination of hear with high intensity magnet
11.0
7.3
13
12
CJG40
NOMESCO Finland
Extraction of dislocated lens with implantation of artificial scleral fixed lens in posterior chamber and iridectomy or iridotomy
+∞
7.3
7
*
26
HP
Aortic root """"composite graft""""
+∞
7.3
7
*
37870
ICD-8 Finland
Other diseases of eye, Subluxatio et luxatio lentis
+∞
7.3
7
*
Q14.8
ICD-10 Finland
Other congenital malformations of posterior segment of eye
+∞
7.3
7
*
Q87.27
ICD-10 Finland
CHARGE association
+∞
7.3
7
*
H65.2
ICD-10 Finland
Chronic serous otitis media
5.3
7.3
21
41
B02AA02
ATC
tranexamic acid; systemic
2.3
7.3
67
311
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.8
7.3
46
174
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
16.0
7.2
11
7
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.4
7.2
40
842
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
7.2
99
547
G40.9
ICD-10 Finland
Epilepsy, unspecified
3.7
7.2
30
85
XKC03
NOMESCO Finland
Water cystometry
5.1
7.2
21
42
Q16.1
ICD-10 Finland
Congenital absence, atresia and stricture of auditory canal (external)
30.4
7.2
9
*
P94.2
ICD-10 Finland
Congenital hypotonia
30.4
7.2
9
*
FCA50
NOMESCO Finland
Resection and reconstruction of ascending aorta using tube graft
30.4
7.2
9
*
74639
ICD-8 Finland
Congenital anomalies of heart, Defectus septi ventriculorum
30.4
7.2
9
*
WX100
NOMESCO Finland
Conjunctival surface anesthesia
3.9
7.2
28
75
Z2445
NOMESCO Finland
Psychologist
2.3
7.1
66
307
M41.4
ICD-10 Finland
Neuromuscular scoliosis
20.3
7.1
10
5
Q23.11
ICD-10 Finland
Bicuspid aortic valve
8.1
7.1
15
19
31
HP
Congenital heart failure surgery
12.2
7.1
12
10
SPAT1231
SPAT
Assessment of adjustments needed in living environment
12.2
7.1
12
10
H25.1
ICD-10 Finland
Senile nuclear cataract
2.9
7.1
42
154
K99
ICPC
Cardiovascular disease other
10.2
7.1
13
13
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
10.2
7.1
13
13
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.4
7.0
60
268
H26.4
ICD-10 Finland
After-cataract
4.6
7.0
23
52
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.7
7.0
196
1361
H33.0
ICD-10 Finland
Retinal detachment with retinal break
7.7
6.9
15
20
137
Kela drug reimbursment
Uraemia requiring dialysis
7.7
6.9
15
20
Q23.10
ICD-10 Finland
Congenital insufficiency of aortic valve
14.0
6.9
11
8
KFH10
NOMESCO Finland
Orchiopexy
11.1
6.8
12
11
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
9.5
6.8
13
14
E23.02
ICD-10 Finland
Neurosecretory dysfunction of the growth hormone
9.5
6.8
13
14
SPAT1262
SPAT
Handing over of treatment supplies
2.1
6.8
75
379
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
3.7
6.8
28
79
I72.8
ICD-10 Finland
Aneurysm and dissection of other specified arteries
40.5
6.8
8
*
F79
ICD-10 Finland
Unspecified mental retardation
40.5
6.8
8
*
7373A
ICD-9 Finland
Curvature of spine, Kyphoscoliosis and scoliosis
40.5
6.8
8
*
NGK20
NOMESCO Finland
Epiphysiodesis of knee or lower leg
40.5
6.8
8
*
Z82.6
ICD-10 Finland
Family history of arthritis and other diseases of the musculoskeletal system and connective tissue
40.5
6.8
8
*
NFK20
NOMESCO Finland
Epiphysiodesis of femur
16.9
6.8
10
6
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.3
6.7
63
293
SPAT1215
SPAT
Assessment of need for medical rehabilitation
3.5
6.7
30
90
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
7.3
6.7
15
21
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
22.8
6.7
9
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.3
6.7
60
274
114
Kela drug reimbursment
Glaucoma
4.0
6.6
25
65
RK110
NOMESCO Finland
NA
7.9
6.6
14
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.3
6.6
31
97
CG2X4
NOMESCO Finland
Optical coherence tomography (OCT) of cornea
12.4
6.6
11
9
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
4.9
6.6
20
42
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.6
6.6
47
193
NF3AA
NOMESCO Finland
Femur X-ray examination
7.0
6.5
15
22
R06.0
ICD-10 Finland
Dyspnoea
1.9
6.5
94
528
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.3
6.5
16
26
C07AB02
ATC
metoprolol; systemic
2.3
6.5
59
273
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.6
6.5
45
181
R31
ICD-10 Finland
Unspecified haematuria
2.9
6.4
38
139
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
7.5
6.4
14
19
ZZG00
NOMESCO Finland
Graft of cartilage
70.5
6.4
7
*
AJ2
HP
Reconstruction of the ascending aorta
70.5
6.4
7
*
I71.6
ICD-10 Finland
Thoracoabdominal aortic aneurysm, without mention of rupture
70.5
6.4
7
*
Q35.3
ICD-10 Finland
Cleft soft palate
70.5
6.4
7
*
4364
FHL
Pharyngeal tongue plastic
70.5
6.4
7
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
2.4
6.4
51
220
WX110
NOMESCO Finland
Local anesthesy
1.6
6.4
397
3351
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
2.3
6.4
59
275
H50.31
ICD-10 Finland
Intermittent exotropia
4.5
6.4
21
48
UDQ12
NOMESCO Finland
Flexible laryngoscopy
3.3
6.4
30
94
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
6.4
46
190
E34.30
ICD-10 Finland
Short stature NOS
6.7
6.4
15
23
H66.9
ICD-10 Finland
Otitis media, unspecified
1.9
6.4
93
526
E34.31
ICD-10 Finland
Short stature, prenatal disorder
8.3
6.4
13
16
H26.2
ICD-10 Finland
Complicated cataract
8.3
6.4
13
16
M21.7
ICD-10 Finland
Unequal limb length (acquired)
8.3
6.4
13
16
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
3.1
6.3
33
112
DFF10
NOMESCO Finland
Measurement of acoustic impedance (tympanometry and reflex testing)
9.4
6.3
12
13
RT490
NOMESCO Finland
NA
9.4
6.3
12
13
61
HP
Catheterization and pressure measurement of the left side of the heart
9.4
6.3
12
13
Q67.6
ICD-10 Finland
Pectus excavatum
18.2
6.3
9
5
R5140
NOMESCO Finland
Monitoring the use of the aid
2.5
6.3
47
197
Q87.23
ICD-10 Finland
Rubinstein-Taybi syndrome
+∞
6.3
6
*
Q87.22
ICD-10 Finland
Nail-patella syndrome
+∞
6.3
6
*
Q71.4
ICD-10 Finland
Longitudinal reduction defect of radius
+∞
6.3
6
*
Q87.00
ICD-10 Finland
Syndrome Treacher Collins
+∞
6.3
6
*
RT290
NOMESCO Finland
NA
+∞
6.3
6
*
7844L
ICD-9 Finland
Symptoms involving head and neck, Voice disturbance[RINOPHONIA SEU RHINOLALIA]
+∞
6.3
6
*
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
7.1
6.2
14
20
Q17.2
ICD-10 Finland
Microtia
26.9
6.2
8
*
H05BX01
ATC
cinacalcet; oral
26.9
6.2
8
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
26.9
6.2
8
*
N03AF02
ATC
oxcarbazepine; oral
3.2
6.2
30
96
SJC00
NOMESCO Finland
Bracket with fixed attachment
12.7
6.1
10
8
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
12.7
6.1
10
8
WX722
NOMESCO Finland
PEEP
3.2
6.1
30
98
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
8.7
6.1
12
14
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
6.8
6.1
14
21
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.8
6.1
115
707
RK320
NOMESCO Finland
NA
10.2
6.0
11
11
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
3.9
6.0
23
61
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.2
6.0
29
93

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
221
714
4.26
61.07
4.8
4.2
ng/l
1131.4
810.9
0.66
195
581
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
111
230
5.66
52.51
3.6
5.2
ng/l
154.4
166.3
0.13
104
206
(3032080) INR in Blood by Coagulation assay
277
1311
3.01
38.85
17.9
5.9
inr
1.5
1.1
3.81
67
387
(3003458) Phosphate [Moles/volume] in Serum or Plasma
189
783
3.03
32.76
11.3
10.0
mmol/l
1.2
1.2
0.39
183
750
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
59
104
6.16
32.67
7.6
23.3
u/ml
0.3
0.3
0.52
32
67
(3022948) Iron [Moles/volume] in Serum or Plasma
168
669
3.07
31.04
3.9
2.7
umol/l
12.5
14.4
2.81
161
630
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
147
569
3.08
28.30
4.2
2.8
%
21.4
24.0
1.60
134
511
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
336
1982
2.52
27.86
16.3
10.1
mmol/l
1.2
1.2
2.54
321
1869
(3024561) Albumin [Mass/volume] in Serum or Plasma
296
1653
2.52
27.55
7.1
6.8
g/l
36.5
37.2
1.25
285
1565
(3004789) Transferrin [Mass/volume] in Serum or Plasma
152
611
2.97
27.27
4.0
2.7
g/l
2.4
2.4
1.27
143
579
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
350
2140
2.46
26.32
15.2
10.1
mmol/l
1.2
1.2
1.64
313
1905
(3023368) Bacteria identified in Blood by Culture
197
942
2.60
25.03
6.1
4.4
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
225
1153
2.49
24.62
2.7
2.9
mg/l
3.1
2.7
0.88
200
1026
(3044640) Blood type and Crossmatch panel - Blood
254
1379
2.43
24.44
3.3
2.8
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
90
282
3.56
24.25
47.5
14.9
inr
1.6
1.2
0.83
11
46
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
56
130
4.63
22.71
1.7
2.2
g/l
1.2
1.3
0.26
45
119
(3012095) Magnesium [Moles/volume] in Serum or Plasma
154
700
2.60
21.30
7.5
8.7
mmol/l
0.8
0.8
0.16
148
668
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
109
417
2.96
20.99
3.6
5.8
u/l
255.0
274.6
0.47
109
405
(42870588) Differential panel, method unspecified - Blood
307
1898
2.22
20.87
7.9
8.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
210
1112
2.34
20.73
7.7
4.0
ph
7.4
7.4
0.34
42
188
(3022096) Basophils/100 leukocytes in Blood
372
2507
2.21
20.09
8.0
8.2
%
0.6
0.7
0.22
355
2382
(3000991) Gas panel - Venous blood
141
632
2.59
19.96
12.5
10.8
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
206
1107
2.29
19.43
3.0
2.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
124
528
2.69
19.43
4.3
6.0
%
1.7
1.6
0.74
119
493
(3006504) Eosinophils/100 leukocytes in Blood
377
2579
2.18
19.28
8.1
8.1
%
3.2
3.0
1.07
361
2446
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
149
697
2.50
19.21
3.8
3.7
ng/l
1536.3
569.9
0.90
115
422
(3001604) Monocytes [#/volume] in Blood
389
2700
2.19
19.08
8.1
8.0
e9/l
0.6
0.6
1.14
347
2304
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
64
187
3.70
19.03
15.9
12.3
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
389
2707
2.18
18.86
8.1
8.0
e9/l
0.0
0.0
1.07
346
2308
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
298
1875
2.14
18.77
3.8
2.9
nmol/l
76.2
71.8
2.04
280
1754
(3019069) Monocytes/100 leukocytes in Blood
377
2596
2.16
18.73
8.3
8.3
%
8.8
8.3
2.82
361
2475
(3013826) Glucose [Moles/volume] in Serum or Plasma
373
2577
2.13
18.12
10.3
6.1
mmol/l
6.1
6.4
2.29
359
2377
(3013115) Eosinophils [#/volume] in Blood
394
2789
2.14
17.83
8.9
8.7
e9/l
0.2
0.2
0.41
353
2428
(3042936) Bacteria identified in Isolate by Culture
128
578
2.53
17.67
2.4
2.1
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
179
944
2.26
17.37
3.1
3.5
mg/l
2.3
1.1
2.01
135
710
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
84
308
3.00
17.31
10.2
18.2
mg/l
1.4
1.1
1.44
79
302
(3019198) Lymphocytes [#/volume] in Blood
392
2800
2.09
16.91
8.1
7.9
e9/l
1.9
2.2
4.99
354
2447
(3002030) Lymphocytes/100 leukocytes in Blood
381
2696
2.08
16.82
8.1
8.0
%
29.2
32.3
5.93
365
2577
(3002582) Erythrocytes [#/volume] in Urine
234
1394
2.09
16.51
5.1
3.6
e6/l
500.5
49.4
0.47
185
1056
(3003396) Base excess in Arterial blood by calculation
90
355
2.79
16.20
14.5
9.7
mmol/l
0.2
0.8
0.55
77
288
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
430
3217
2.10
15.88
8.8
6.7
u/l
93.5
92.7
0.09
412
3047
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
308
2050
2.00
15.78
4.5
4.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
308
2050
2.00
15.78
7.4
7.2
umol/l
15.9
15.9
0.01
292
1942
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
251
1559
2.03
15.60
5.4
3.7
—
—
—
0
0
(3012544) pH of Venous blood
140
696
2.31
15.44
8.7
9.9
—
7.3
—
0
5
(3018095) Leukocytes [#/volume] in Urine
262
1670
1.99
14.98
5.9
4.1
e6/l
169.8
41.6
0.52
190
1121
(3018010) Neutrophils/100 leukocytes in Blood
371
2665
1.98
14.92
8.0
7.8
%
55.1
52.9
2.93
354
2544
(3002032) Base excess in Venous blood by calculation
137
685
2.28
14.86
8.7
9.8
mmol/l
1.8
1.3
0.94
121
551
(3044889) 12 lead EKG panel
371
2669
1.97
14.81
4.3
2.8
—
—
—
0
0
(40758558) Short blood count panel - Blood
235
1457
1.99
14.42
9.4
8.7
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
563
4784
2.98
14.36
25.1
12.5
mmol/l
139.4
139.6
1.66
555
4662
(3023103) Potassium [Moles/volume] in Serum or Plasma
563
4792
2.96
14.16
25.6
12.6
mmol/l
4.0
3.9
4.86
555
4649
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
214
1301
1.98
13.77
2.0
1.7
pmol/l
98.2
96.5
0.19
116
689
(3013650) Neutrophils [#/volume] in Blood by Automated count
402
3015
1.95
13.70
11.7
10.6
e9/l
3.8
3.8
0.06
360
2571
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
14
12
11.91
13.56
1.2
1.7
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
166
935
2.06
13.14
4.5
2.8
e6/l
5.3
6.3
0.38
147
816
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
70
272
2.77
12.89
3.3
2.6
ml/min/173m2
69.9
76.3
0.48
31
106
(3023520) Reticulocytes [#/volume] in Blood
87
378
2.51
12.82
2.6
4.9
e9/l
83.5
68.6
1.72
58
262
(3026008) Bacteria identified in Urine by Culture
180
1057
1.99
12.61
3.4
2.5
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
15
16
9.58
12.58
1.5
1.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
209
1295
1.93
12.49
5.2
3.4
e6/l
0.3
0.3
0.15
167
964
(36304419) Bacteria [Presence] in Urine
210
1306
1.92
12.40
5.0
3.4
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
34
86
4.12
12.33
4.1
4.4
%
12.8
9.4
1.09
28
75
(3021960) Folate [Moles/volume] in Serum or Plasma
135
724
2.10
12.08
1.7
1.4
nmol/l
20.9
20.0
0.27
121
639
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
113
567
2.21
11.97
8.2
9.8
mmol/l
23.8
23.6
0.34
108
543
(3021589) Normoblasts [#/volume] in Blood
341
2489
1.82
11.93
11.7
10.2
e9/l
0.0
0.0
0.50
282
1950
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
117
597
2.18
11.88
2.5
2.0
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
36
98
3.84
11.82
4.4
4.1
e9/l
1.3
1.3
0.05
29
61
(3015377) Calcium [Moles/volume] in Serum or Plasma
204
1274
1.90
11.78
4.2
3.1
mmol/l
2.4
2.4
0.91
187
1159
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
28
65
4.46
11.33
7.8
5.1
—
—
—
0
0
(3026782) Osmolality of Urine
154
890
1.97
11.13
4.5
2.9
mosm/kgh2o
559.4
586.0
0.61
137
762
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
32
84
3.96
11.05
4.3
4.5
—
—
—
0
0
(3009343) pH of Capillary blood
117
617
2.10
10.86
13.2
9.7
ph
7.4
7.4
—
9
25
(3026250) Tacrolimus [Mass/volume] in Blood
22
43
5.26
10.85
31.9
43.8
ug/l
6.5
6.9
0.44
22
37
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
20
37
5.55
10.45
2.5
1.7
%
123.7
137.4
0.53
20
37
(3024928) Oxygen saturation in Venous blood
36
107
3.51
10.42
12.0
12.9
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
115
613
2.07
10.34
13.3
9.7
mmol/l
1.7
1.1
1.35
92
454
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
171
1047
1.87
10.29
2.3
2.3
u/l
321.4
288.3
0.16
164
1003
(3006184) Hemoglobin [Mass/volume] in Capillary blood
32
91
3.65
9.89
2.9
2.8
g/l
134.8
132.2
0.23
24
69
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
52
199
2.76
9.84
1.8
1.7
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
112
603
2.05
9.77
2.4
1.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
133
761
1.95
9.77
3.7
3.3
e6/l
2.3
2.2
0.11
84
416
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
13
16
8.27
9.76
1.8
1.6
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
320
2388
1.70
9.54
4.3
3.2
ug/l
126.5
83.6
1.19
300
2257
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
135
788
1.91
9.31
3.7
3.1
e6/l
0.9
0.7
0.19
85
445
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
28
77
3.76
9.08
3.5
3.3
e6/l
661.6
760.5
—
5
17
(3031040) Bacteria [#/volume] in Urine by Automated count
367
2874
1.68
8.85
5.6
3.8
e6/l
565.0
481.2
0.05
12
31
(3022313) Gas panel - Capillary blood
100
535
2.04
8.84
12.0
9.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
89
460
2.09
8.62
1.8
1.6
nmol/l
1077.1
1159.0
0.39
71
366
(3021901) Oxygen saturation in Capillary blood
27
76
3.67
8.48
6.0
6.2
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
227
1599
1.66
8.05
3.5
4.1
u/l
36.1
31.4
0.51
222
1532
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
456
3831
1.72
8.00
19.0
8.8
ml/min/173m2
96.0
94.7
0.44
378
2927
(3004588) Protein electrophoresis panel - Serum or Plasma
38
140
2.82
7.74
1.4
2.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
69
337
2.18
7.72
4.4
2.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
135
2.85
7.67
1.5
1.9
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
578
5265
2.50
7.65
18.6
9.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
25
72
3.57
7.61
3.2
2.9
%
17.7
16.4
1.09
17
35
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
447
3759
1.68
7.55
4.7
3.7
pmol/l
14.8
14.4
2.60
426
3495
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
84
448
2.01
7.45
2.5
2.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
173
1156
1.69
7.39
3.9
2.9
ng/l
24.8
43.5
0.66
116
601
(1616796) Gas panel - Central venous blood
26
81
3.30
7.04
6.9
4.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
82
443
1.98
7.01
2.5
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
384
3146
1.58
6.86
5.9
4.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
56
264
2.23
6.83
1.9
1.7
—
—
—
0
0
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
13
25
5.29
6.51
2.0
3.7
ug/l
152.6
182.4
0.17
13
25
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
25
80
3.21
6.50
1.5
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
497
4374
1.69
6.25
5.3
4.3
mu/l
1.9
2.1
0.35
477
4122
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
555
5047
1.97
6.20
21.9
11.5
mg/l
28.4
21.2
4.54
458
3677
(3000494) Fungus identified in Specimen by Culture
87
500
1.86
6.18
1.6
1.5
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
28
99
2.91
6.17
7.9
10.7
mmol/l
1.3
1.1
0.97
28
86
(3044941) Cell count panel - Synovial fluid
16
39
4.18
6.11
1.8
1.3
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
73
399
1.94
6.03
1.9
1.8
iu/l
18.4
17.4
0.08
54
309
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
16
6.33
5.96
1.0
2.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
520
4656
1.73
5.85
26.6
15.0
%
13.7
13.3
4.75
511
4592
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
15
36
4.24
5.84
1.4
1.0
%
96.9
90.8
—
7
19
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
30
114
2.71
5.81
1.7
1.6
—
—
—
0
0
(3013512) EKG study
128
841
1.66
5.69
3.8
3.0
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
46
216
2.22
5.69
2.0
3.5
g/l
64.7
66.1
0.51
46
204
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
30
118
2.62
5.45
3.9
2.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
31
126
2.54
5.28
2.1
2.0
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
76
441
1.82
5.23
2.7
2.2
nmol/l
11.4
12.6
0.51
64
385
(3002256) Pathology report gross observation
79
464
1.80
5.23
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
30
121
2.55
5.19
2.0
1.8
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
14
35
4.07
5.19
1.8
1.1
%
77.8
90.5
—
6
18
(3027315) Oxygen [Partial pressure] in Blood
23
84
2.80
4.82
6.5
5.4
kpa
9.1
9.0
0.15
23
84
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
48
246
2.03
4.78
7.1
5.1
mmol/l
1.2
1.2
0.34
43
221
(3015736) pH of Urine
225
1738
1.46
4.72
4.2
3.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
91
2.70
4.70
1.5
1.9
g/l
3.7
3.8
0.07
19
69
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
24
91
2.70
4.70
1.5
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
92
583
1.68
4.66
5.2
5.5
umol/l
5.4
7.1
1.14
73
499
(3009508) Creatinine [Moles/volume] in Urine
175
1289
1.50
4.65
5.4
3.8
mmol/l
7.4
8.5
2.41
162
1153
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
48
3.39
4.63
1.3
2.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
167
1220
1.50
4.62
2.7
2.9
u/l
56.4
56.0
0.03
154
1141
(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum
7
5
14.13
4.58
1.1
1.6
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
59
330
1.87
4.57
2.3
2.0
u/l
5.6
7.5
1.05
34
245
(3037121) Protein [Mass/volume] in Urine
42
210
2.07
4.47
4.5
6.6
g/l
0.3
0.3
0.32
26
146
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
12
30
4.06
4.45
1.6
1.9
nmol/l
20.3
16.2
—
6
10
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
95
616
1.64
4.40
1.5
1.6
pmol/l
435.8
27027474.5
0.80
78
555
(3020682) Albumin/Creatinine [Ratio] in Urine
127
883
1.55
4.40
6.2
4.1
mg/mmol
16.0
28.8
0.30
97
602
(3013290) Carbon dioxide [Partial pressure] in Blood
22
84
2.68
4.27
6.5
5.4
kpa
5.1
5.0
0.58
22
84
(3012501) Base excess in Blood by calculation
22
84
2.68
4.27
6.5
5.4
mmol/l
2.0
2.5
0.61
15
48
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
28
122
2.35
4.16
1.8
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
28
122
2.35
4.16
1.8
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
33
155
2.19
4.13
2.0
2.0
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
10
23
4.40
4.10
4.4
2.7
e9/l
0.3
0.2
—
10
23
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
99
2.48
4.01
2.2
2.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
93
2.53
4.00
1.6
1.7
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
268
2186
1.40
4.00
4.9
3.2
estimate
0.0
0.0
0.00
56
407
(3026493) Urate [Moles/volume] in Serum or Plasma
129
919
1.51
3.97
3.3
3.3
umol/l
3553.4
4096.7
0.06
120
841
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
33
3.69
3.93
6.8
10.3
—
—
—
0
0
(3019225) pH of Specimen
50
279
1.86
3.92
4.0
4.4
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
13
38
3.47
3.91
1.2
2.0
nmol/l
2.2
3.6
0.79
13
38
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
22
88
2.55
3.91
4.6
4.5
%
55.5
54.7
0.10
22
88
(21494814) CD8 cells/100 lymphocytes in Specimen
8
11
7.35
3.86
3.3
3.5
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
8
11
7.35
3.86
3.4
3.6
%
13.8
6.8
—
8
11
(3011648) Oxygen content in Venous blood
17
60
2.88
3.81
20.6
18.4
%
11.0
12.0
0.69
17
60
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
43
231
1.92
3.79
1.6
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
148
1094
1.46
3.78
1.6
1.8
mmol/l
1.7
1.4
1.66
135
978
(44790047)
25
109
2.35
3.73
2.2
2.2
—
—
—
0
0
(44790048)
25
109
2.35
3.73
2.2
2.2
—
—
—
0
0
(44806118)
25
109
2.35
3.73
2.2
2.2
—
—
—
0
0
(44790049)
25
109
2.35
3.73
2.2
2.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
82
535
1.61
3.71
2.5
2.5
mmol/l
2.4
2.4
0.29
69
459
(3005719) IgG [Mass/volume] in Serum or Plasma
76
487
1.64
3.70
4.3
3.3
g/l
9.7
9.5
0.22
68
454
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
26
3.89
3.53
3.5
9.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
26
3.89
3.53
3.5
9.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
119
854
1.49
3.52
5.6
3.5
mg/l
102.4
375.0
1.14
97
589
(40768446) Kidney Pathology biopsy report
13
41
3.22
3.51
2.0
2.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
67
424
1.65
3.43
2.8
2.6
u/l
30.5
32.5
0.24
62
357
(3030905) Polymorphonuclear cells [#/volume] in Blood
21
88
2.43
3.42
3.8
4.1
e9/l
3.3
4.0
0.82
21
88
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
44
247
1.84
3.41
3.2
4.3
ug/l
4.9
22.3
0.48
28
197
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
18
70
2.62
3.40
1.4
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
18
70
2.62
3.40
1.7
1.7
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
68
434
1.64
3.37
1.4
1.4
u/ml
242.9
262.5
0.06
63
399
(3029937) Albumin [Presence] in Urine by Test strip
147
1108
1.43
3.36
5.2
3.4
estimate
0.0
0.0
0.45
54
413
(3024891) Influenza virus A+B Ag [Presence] in Specimen
40
219
1.88
3.35
1.5
1.2
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
12
37
3.29
3.35
1.3
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
42
234
1.85
3.34
1.7
1.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
143
1074
1.43
3.33
3.7
3.2
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
19
77
2.51
3.32
1.6
1.9
g/l
37.7
39.7
0.56
19
69
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
33
170
1.99
3.30
7.7
6.8
%
48.9
54.2
0.52
33
170
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
28
535
0.50
3.29
1.4
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
409
3640
1.36
3.26
5.3
4.4
mmol/mol
36.6
38.1
3.13
389
3471
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
31
157
2.02
3.25
2.0
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
19
78
2.48
3.24
2.3
2.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
263
2195
1.34
3.20
6.8
4.5
estimate
0.0
0.0
0.00
56
427
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
30
151
2.04
3.20
1.6
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
544
5099
1.55
3.17
12.8
9.2
u/l
27.3
27.3
0.01
533
4955
(3003694) ABO and Rh group [Type] in Blood
200
1604
1.36
3.14
1.5
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
265
2223
1.33
3.08
5.0
3.2
estimate
0.0
0.0
0.00
54
402
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
472
0.49
3.08
1.4
1.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
381
3375
1.33
3.01
4.8
4.0
mm/h
10.9
8.6
2.49
358
3155
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
15
57
2.67
2.98
3.9
5.6
ug/l
2.2
2.1
0.03
15
57
(3042733) HLA Ab [Presence] in Serum
11
35
3.18
2.94
6.8
2.7
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
11
35
3.18
2.94
2.7
2.8
%
36.5
43.1
—
6
9
(3026361) Erythrocytes [#/volume] in Blood
601
5808
2.24
2.86
31.1
16.8
e12/l
4.5
4.6
5.13
595
5620
(3019060) Gas panel - Arterial blood
33
180
1.88
2.83
8.9
7.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
601
5811
2.22
2.80
31.3
16.9
e9/l
6.7
6.7
0.04
596
5621
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
18
378
0.46
2.79
1.3
1.3
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
6
8.38
2.75
4.6
5.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
59
384
1.59
2.73
2.2
1.9
g/l
1.1
1.1
0.12
54
360
(40760888) Immunoglobulin light chains.free panel - Serum
13
48
2.74
2.73
1.4
4.0
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
24
3.79
2.68
1.7
3.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
195
1593
1.33
2.64
2.0
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
15
4.70
2.60
1.3
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
26
470
0.53
2.60
1.2
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
25
3.63
2.58
1.0
1.3
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
25
3.63
2.58
1.0
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
42
663
0.61
2.56
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
14
312
0.44
2.56
1.9
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
24
122
2.00
2.53
1.3
1.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
282
0.41
2.50
2.1
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
25
130
1.96
2.48
1.3
1.4
ug/g
355.5
313.6
0.56
18
66
(3021788) Differential panel - Synovial fluid
13
51
2.58
2.45
1.2
1.6
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
6
12
5.03
2.40
2.2
3.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
14
58
2.44
2.38
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
8
6.29
2.37
6.4
2.8
—
—
—
0
0
(3024263) Appearance of Synovial fluid
5
8
6.29
2.37
3.0
1.5
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
71
500
1.47
2.32
1.6
1.5
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
28
475
0.57
2.27
1.5
2.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
7
18
3.92
2.25
1.1
1.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
28
472
0.57
2.22
1.5
2.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
12
48
2.53
2.19
1.6
1.5
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
42
2.65
2.19
1.3
1.5
nmol/l
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
28
470
0.58
2.18
1.5
2.1
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
11
252
0.43
2.18
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
11
252
0.43
2.18
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
11
252
0.43
2.18
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
11
251
0.43
2.16
1.5
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
705
0.65
2.14
2.0
2.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
19
95
2.03
2.12
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
12
49
2.48
2.11
1.1
1.3
—
—
—
0
0
(4062490)
16
75
2.16
2.10
1.3
1.4
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
5
10
5.03
2.07
1.0
1.1
u/l
14.6
14.7
—
5
10
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
13
273
0.46
2.07
1.4
1.5
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
15
4.03
2.04
1.0
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
21
111
1.92
2.03
1.2
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
8
26
3.10
2.02
8.0
6.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
8
26
3.10
2.02
2.5
2.0
—
18.2
—
0
10
(3009466) Valproate [Moles/volume] in Serum or Plasma
20
106
1.92
1.92
5.5
5.0
umol/l
431.6
392.5
0.61
20
97
(3021440) Promyelocytes/100 leukocytes in Blood
47
318
1.52
1.89
5.1
5.7
%
0.2
0.1
0.22
13
95
(3038515) Glucose [Moles/volume] in Venous blood
12
52
2.33
1.88
3.6
3.7
mmol/l
5.5
7.1
3.42
12
52
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
19
100
1.93
1.87
1.8
1.9
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
13
59
2.23
1.85
1.7
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
33
207
1.63
1.83
2.4
1.9
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
28
447
0.61
1.83
1.5
2.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
24
138
1.77
1.81
1.3
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
85
1094
0.74
1.81
2.0
1.7
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
17
87
1.98
1.81
1.4
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
87
1.98
1.81
1.3
1.7
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
21
117
1.82
1.76
2.6
2.8
u/ml
318.5
56.4
0.63
16
100
(3052851) Hemolysis interference index of Serum or Plasma
25
148
1.72
1.72
3.4
3.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
24
2.94
1.72
1.1
1.4
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
13
61
2.15
1.72
4.5
4.5
umol/l
24.8
25.5
0.11
13
61
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
5
13
3.87
1.71
2.0
2.9
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
13
3.87
1.71
5.0
15.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
82
1.98
1.70
1.3
1.4
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
22
366
0.59
1.70
2.9
2.3
—
17.3
—
0
23
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
85
1082
0.75
1.68
2.3
2.2
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
10
42
2.40
1.68
1.6
2.5
pg
33.7
32.8
—
10
42
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
62
2.12
1.66
1.4
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
62
2.12
1.66
1.9
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
565
0.67
1.66
1.8
1.9
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
7
25
2.82
1.65
2.4
3.3
umol/l
1.1
1.1
—
7
25
(40761536) Microorganisms panel - Urine sediment
52
371
1.44
1.64
7.6
3.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
91
1.89
1.61
2.6
2.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
43
2.35
1.60
4.4
5.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
43
2.35
1.60
4.4
5.1
—
—
—
0
0
(4035726)
46
322
1.46
1.60
1.4
1.6
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
206
0.48
1.56
1.5
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
44
308
1.46
1.54
5.3
5.7
%
0.0
0.0
0.74
11
81
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
28
177
1.61
1.54
1.3
1.5
—
405.7
—
0
7
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
256
0.54
1.53
1.2
1.4
miu/ml
150.8
264.9
—
7
131
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
15
3.35
1.52
3.2
2.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
1184
0.78
1.50
2.2
2.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
5
16
3.14
1.44
1.2
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
16
3.14
1.44
1.0
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
6
22
2.74
1.43
1.3
1.2
—
—
—
0
0
(4024509)
6
22
2.74
1.43
2.7
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
39
2.33
1.43
1.0
1.4
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
225
0.52
1.43
1.5
1.6
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
10
46
2.19
1.40
1.1
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
6
23
2.62
1.37
3.0
2.8
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
19
112
1.72
1.36
1.7
2.0
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
17
2.95
1.36
3.0
1.9
ml
1614.8
2165.6
—
5
17
(3017181) Myelocytes/100 leukocytes in Blood
47
343
1.40
1.34
5.1
5.5
%
1.6
0.6
0.74
14
107
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
6
24
2.51
1.30
3.8
8.0
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
6
24
2.51
1.30
3.5
7.5
—
—
—
0
0
(3016750) Collection duration of Urine
6
24
2.51
1.30
4.2
2.5
min
512.7
522.0
—
6
13
(4306422)
14
76
1.86
1.30
1.4
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
73
914
0.77
1.29
1.8
1.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
142
1211
1.22
1.29
5.2
2.7
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.4
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
18
2.79
1.28
4.2
1.6
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
18
2.79
1.28
1.2
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
426
4011
1.20
1.28
4.0
3.3
mmol/l
5.7
5.7
0.18
400
3734
(4268621)
12
62
1.95
1.28
3.2
2.2
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
8
35
2.30
1.27
3.9
3.0
u/ml
670.6
732.9
—
8
35
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
51
382
1.36
1.26
3.1
3.4
%
31.6
31.3
0.06
42
275
(40760892) CBC W Ordered Manual Differential panel - Blood
132
1120
1.23
1.26
5.4
4.9
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
43
313
1.40
1.26
4.2
5.2
%
0.4
0.3
—
9
75
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
16
92
1.76
1.26
1.8
2.0
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
6
25
2.41
1.24
4.0
2.7
ml
720.0
631.1
—
6
13
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
15
85
1.78
1.23
1.7
1.3
u/ml
1.4
5.8
—
8
33
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
85
1.78
1.23
1.6
1.3
u/ml
4.2
4.5
—
10
41
(3002619) Bacteria identified in Specimen by Culture
5
19
2.64
1.21
1.0
1.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
8
37
2.18
1.21
1.6
3.2
nmol/l
2.4
3.1
—
8
37
(1761868) Lipid panel - Serum or Plasma
144
1660
0.83
1.21
2.5
2.3
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
21
132
1.61
1.21
1.2
1.4
nmol/l
0.5
0.4
0.29
16
107
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
185
1630
1.19
1.19
5.2
3.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
8
39
2.06
1.15
1.3
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
8
39
2.06
1.15
1.5
1.2
%
69.8
76.0
—
8
39
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
8
39
2.06
1.15
1.5
1.3
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
36
0.00
1.14
0.0
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
30
2.35
1.12
2.1
2.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
374
0.68
1.12
1.6
2.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
31
2.27
1.10
1.3
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.4
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.4
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.4
1.6
—
—
—
0
0
(3022145) Colonoscopy Study observation
56
438
1.31
1.07
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
12
67
1.81
1.05
2.1
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
12
67
1.81
1.05
1.0
1.4
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
46
1.97
1.04
7.2
4.3
ug/l
22.2
27.4
—
9
46
(21494890) Protein electrophoresis panel - 24 hour Urine
5
22
2.28
1.03
1.2
3.1
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
75
1.75
1.03
1.5
1.8
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
11
60
1.85
1.03
1.5
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
7
34
2.07
1.03
1.0
1.1
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
26
180
1.46
1.02
2.1
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
528
5113
1.22
0.97
26.1
13.4
%
39.3
40.3
3.84
435
4345
(3028707) Methadone [Presence] in Urine by Screen method
14
222
0.62
0.96
1.8
2.8
—
—
—
0
0
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
13
77
1.70
0.95
1.0
1.0
g/l
1.5
1.4
0.45
13
70
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
166
1.46
0.95
1.2
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
160
1792
0.85
0.95
1.9
1.8
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
9
51
1.77
0.94
1.6
1.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
27
2.23
0.93
3.2
3.7
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
10
55
1.83
0.92
3.5
2.4
umol/l
13.8
15.1
—
10
55
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
442
4227
1.16
0.90
4.4
3.7
mmol/l
2.8
2.8
0.60
424
3994
(3028433) Virus identified in Specimen by Culture
6
29
2.08
0.89
1.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
8
42
1.92
0.89
1.3
1.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
32
238
1.36
0.87
2.1
1.9
u/ml
299.1
184.5
0.90
20
125
(3025941) Bacteria identified in Stool by Culture
36
273
1.34
0.87
1.1
1.2
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
12
72
1.68
0.85
1.8
1.5
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
171
1.42
0.84
1.2
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
46
1.75
0.82
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
11
65
1.70
0.82
1.6
2.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
32
1.88
0.82
4.2
2.8
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
6
32
1.88
0.82
4.2
2.8
mmol/l
101.5
105.6
—
6
32
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
6
32
1.88
0.82
1.0
1.0
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
6
32
1.88
0.82
4.2
2.8
mmol/l
4.0
4.0
—
6
32
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
24
0.00
0.79
0.0
1.5
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
19
131
1.46
0.79
1.9
1.7
pmol/l
189.0
222.5
0.57
19
126
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
48
1.67
0.79
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
97
0.51
0.78
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
165
1.41
0.78
1.2
1.1
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
26
191
1.38
0.78
2.0
1.6
nmol/l
37.7
37.3
0.02
26
186
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
46
369
1.27
0.76
3.0
2.5
u/l
11006.5
3953.4
0.43
15
152
(3003740) Influenza virus B Ag [Presence] in Specimen
23
166
1.40
0.76
1.3
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
439
4218
1.14
0.75
4.2
3.6
mmol/l
4.5
4.6
3.08
421
4020
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
343
3247
1.13
0.75
3.8
3.7
u/l
49.6
37.9
1.73
325
3129
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
172
0.63
0.75
1.3
1.5
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
24
2.09
0.74
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
23
167
1.39
0.74
1.3
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
421
4037
1.13
0.74
3.8
3.2
mmol/l
1.3
1.2
1.32
402
3826
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
435
4180
1.14
0.74
4.1
3.5
mmol/l
1.3
1.4
9.29
417
3964
(36660697) Celiac disease serology panel - Serum
79
676
1.19
0.73
1.1
1.2
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
20
142
1.42
0.73
2.5
1.9
iu/l
4.1
5.5
—
9
52
(3026389) Candida sp identified in Specimen by Organism specific culture
9
56
1.61
0.72
1.3
1.3
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
9
56
1.61
0.72
4.2
3.9
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
9
56
1.61
0.72
1.1
1.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
169
1536
1.14
0.72
1.7
1.6
g/l
1.9
1.9
0.09
91
861
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
26
1.93
0.70
1.0
1.6
g/l
1.0
1.0
—
5
26
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
9
142
0.63
0.70
1.2
2.2
nmol/l
0.7
0.6
—
9
121
(40768797) Stomach Pathology biopsy report
64
539
1.21
0.70
1.5
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
14
93
1.52
0.70
1.5
1.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
24
178
1.36
0.69
2.1
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
91
0.55
0.67
1.6
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
94
0.53
0.67
1.0
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
31
242
1.29
0.65
2.0
1.9
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
81
703
1.17
0.65
1.5
1.4
titre
261.5
426.0
0.90
13
131
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
29
1.73
0.64
6.6
3.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
5
29
1.73
0.64
2.0
2.7
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
129
1.41
0.64
1.2
1.2
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
8
49
1.64
0.62
1.3
1.3
pmol/l
260.8
543.7
—
8
42
(44813793)
8
50
1.61
0.61
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
22
288
0.75
0.60
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
8
51
1.57
0.60
1.3
1.3
mu/l
29.1
216.1
—
8
46
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
0
20
0.00
0.60
0.0
1.1
—
20.6
—
0
10
(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
3.7
—
0
12
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
52
1.54
0.59
2.5
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
110
985
1.14
0.59
4.6
3.2
kg/l
1.0
1.0
1.58
26
150
(46235355) HIV 1 and 2 tests - Meaningful Use set
136
1490
0.89
0.59
2.4
2.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
7
115
0.60
0.58
1.3
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
50
421
1.20
0.57
1.5
1.3
iu/ml
203.8
165.8
0.16
14
156
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
6
36
1.67
0.56
1.3
1.2
iu/ml
356.2
182.0
—
6
36
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
87
0.57
0.56
1.0
1.8
—
—
—
0
0
(1002224) Polysomnography panel
27
212
1.29
0.56
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
10
65
1.55
0.55
4.6
3.8
—
—
—
0
0
(3000492) Spirometry study
58
497
1.18
0.55
1.6
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
26
327
0.79
0.54
6.3
3.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
6
38
1.58
0.54
1.5
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
38
1.58
0.54
1.3
1.6
—
—
—
0
0
(3024932) HLA-DR beta [Type]
6
40
1.50
0.51
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
62
708
0.86
0.50
1.5
1.2
u/ml
15.4
7.2
0.33
24
275
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
7
45
1.56
0.49
1.0
1.4
—
—
—
0
0
(40768441) Liver Pathology biopsy report
7
45
1.56
0.49
1.3
2.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
11
76
1.45
0.48
1.1
1.7
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
7
47
1.49
0.47
1.1
1.1
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
49
1.43
0.46
1.1
1.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
29
237
1.23
0.46
2.8
2.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
18
231
0.77
0.45
1.4
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
14
103
1.37
0.45
1.1
1.2
—
19.1
—
0
7
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
441
4519
0.91
0.45
3.7
3.8
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
24
296
0.80
0.45
1.1
1.2
u/ml
3.5
2.4
0.24
16
173
(40761535) Cells panel - Urine sediment
31
258
1.21
0.42
4.2
3.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
33
1.52
0.41
1.6
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
17
0.00
0.40
0.0
1.4
—
—
—
0
0
(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
1.8
—
0
9
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
10.3
—
0
10
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
177
1665
1.09
0.40
1.4
1.6
u/ml
1.7
2.3
0.18
45
372
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
17
132
1.30
0.40
1.4
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
10
71
1.41
0.39
1.1
1.3
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
9
68
1.33
0.37
6.7
3.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
98
1.33
0.37
1.0
1.2
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
13
98
1.33
0.37
1.0
1.2
—
1.3
—
0
5
(4010399)
33
281
1.18
0.37
2.1
1.4
—
—
—
0
0
(3024471) HLA-A [Type]
6
41
1.47
0.36
1.0
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
76
0.65
0.36
1.2
4.5
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
145
0.75
0.35
1.1
1.1
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
25
209
1.20
0.34
1.5
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
155
0.77
0.33
1.0
1.1
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
100
926
1.09
0.33
2.6
3.1
ug/g
99.5
96.2
0.06
83
749
(3017143) Hepatitis C virus Ab [Presence] in Serum
89
820
1.10
0.33
2.3
1.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
26
305
0.85
0.32
1.7
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
47
526
0.88
0.32
1.6
1.9
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
23
272
0.84
0.31
1.1
1.2
u/ml
1.5
7.3
4.41
18
189
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
25
292
0.85
0.30
1.6
1.6
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
12
93
1.30
0.30
1.8
1.3
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
13
163
0.79
0.30
1.1
1.1
u/ml
4.2
0.5
—
6
60
(3020961) Endomysium IgA Ab [Titer] in Serum
41
459
0.89
0.28
1.1
1.3
—
72.8
—
0
16
(3014148) Varicella zoster virus Ab [Titer] in Serum
15
121
1.24
0.28
1.5
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
258
0.85
0.28
1.6
1.8
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(3020891) Body temperature
17
140
1.22
0.27
20.6
6.5
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
23
267
0.86
0.26
1.1
1.2
u/ml
1.6
1.1
0.12
14
177
(4094501)
6
83
0.72
0.24
1.0
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
23
264
0.87
0.23
1.1
1.2
u/ml
5.2
3.0
—
8
83
(3035320) C reactive protein [Mass/volume] in Body fluid
5
39
1.28
0.23
3.0
2.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
92
0.76
0.22
1.1
5.7
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
41
1.22
0.22
1.0
1.0
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
5
41
1.22
0.22
1.2
1.2
u/ml
13.6
3.6
—
5
36
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
212.2
—
0
6
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.0
—
650.8
—
0
6
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
31.8
—
0
6
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
50
1.20
0.19
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
51
1.18
0.19
1.5
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
11
132
0.83
0.18
1.1
4.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
368
1.09
0.17
6.5
5.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
7
62
1.13
0.17
1.0
1.1
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
5
66
0.76
0.17
1.0
1.3
—
353.0
—
0
10
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
12
141
0.85
0.16
1.1
4.1
mmol/l
3.5
3.4
0.29
12
134
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
8
70
1.14
0.16
2.1
1.8
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
16
182
0.88
0.15
1.1
1.1
u/ml
5.2
5.8
—
8
91
(3008757) Leukocyte morphology finding [Identifier] in Blood
10
83
1.21
0.15
2.6
4.5
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
9
81
1.11
0.15
1.3
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
11
93
1.19
0.14
1.8
1.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
17
150
1.14
0.14
1.1
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
60
631
0.94
0.13
3.1
3.4
%
24.5
21.4
0.37
16
232
(3006598) pH of Arterial cord blood
9
106
0.85
0.13
1.0
1.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
94
1.17
0.13
1.4
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
14
157
0.89
0.11
1.1
1.9
—
—
—
0
0
(4034850)
12
136
0.88
0.11
12.5
9.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
10
115
0.87
0.11
1.1
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
135
0.89
0.10
1.0
1.9
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
15
166
0.90
0.10
1.1
1.1
u/ml
6.4
7.0
—
10
86
(4027681)
5
44
1.14
0.10
1.4
1.2
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
46
1.09
0.09
1.0
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
83
803
1.04
0.09
3.2
3.7
ug/l
1.5
1.6
0.11
78
727
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
48
1.04
0.09
1.0
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
50
478
1.05
0.09
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
165
1.09
0.08
1.6
1.6
iu/ml
0.0
0.0
—
6
39
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
66
1.06
0.08
1.1
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
44
458
0.96
0.07
2.1
2.5
ug/l
0.7
0.7
0.10
28
244
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
24
255
0.94
0.07
1.0
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
43
413
1.04
0.06
1.9
1.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
116
1182
0.98
0.06
2.1
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
31
295
1.05
0.06
1.2
1.2
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
17
158
1.08
0.06
1.1
1.1
—
9.3
—
0
7
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
79
807
0.98
0.05
1.3
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
17
178
0.95
0.02
1.6
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
25
242
1.03
0.02
1.2
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
10
98
1.02
0.00
6.7
3.4
u/ml
78.9
3.5
—
10
90
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
15
151
0.99
0.00
1.1
4.0
mg/l
279.3
403.4
1.67
15
146
(3000330) Specific gravity of Urine by Test strip
17
169
1.01
0.00
4.4
2.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
37
367
1.01
0.00
1.3
1.3
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
74
743
0.99
0.00
1.4
1.3
iu/ml
40.7
25.5
0.21
21
215
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
170
1.00
0.00
1.5
1.4
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
7
0.00
0.00
0.0
4.4
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
1.7
—
0
7
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008402) Methanol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
5
56
0.89
0.00
1.6
1.5
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
5
54
0.92
0.00
1.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
5
54
0.92
0.00
1.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3042517) Benzodiazepines panel - Urine
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
8
0.00
0.00
0.0
5.0
—
3.6
—
0
8
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
5
54
0.92
0.00
1.0
1.2
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.9
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
5
55
0.91
0.00
1.0
1.2
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
87
0.92
0.00
1.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
5
0.00
0.00
0.0
1.8
—
2.3
—
0
5
(3020356) Listeria sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.6
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760410) HLA-B [Type] by High resolution
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS and mortality.

Females

Parameter HR [95% CI] p-value
Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS 4.369 [3.04, 6.28] < 0.001
Birth year 0.994 [0.99, 1.0] 0.176

During the follow-up period (1.1.1998 — 31.12.2019), 139 out of 2512 females with Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS died.

Males

Parameter HR [95% CI] p-value
Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS 4.099 [3.26, 5.16] < 0.001
Birth year 0.987 [0.98, 1.0] 0.006

During the follow-up period (1.1.1998 — 31.12.2019), 192 out of 2556 males with Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS died.

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS.

N-year risk Females Males
1 0.44% 0.835%
5 2.571% 4.97%
10 6.367% 12.307%
15 11.887% 21.957%
20 20.333% 34.286%

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_SPECIFE_CONGEN_MALFO_SYNDR_AFFECTING_MULTIPLE_SYSTEMS – Other specified congenital malformation syndromes affecting multiple systems

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data